An ever-evolving platform for digital intervention.
Never-ending growth.
MDTx is creating a unified platform for digital therapeutics. We launched with SpeechATTAX, a communication therapy tailored to progressive neurological disorders. The MDTx platform will continue to expand across domains of cognition, movement, paediatrics, and beyond. A shared technological layer will serve as the undercurrent of engagement, care, outcome measurement, personalisation, and clinician interaction. This architecture also supports the development of new therapeutics across neurological and other disorders.
Dynamic and intelligent.
MDTx builds reusable capability across all aspects of therapy. This includes systems for the precise capture and analysis of clinical outcomes, interventions tailored to individual needs, and clinician interfaces for reviewing patient progress. As the platform expands into other therapeutic domains, new applications will contribute capabilities that can be used across the wider portfolio.